The first round of IRA implementation begins January 1, 2024. Join our speakers as they dive into the realities of the IRA implementation from early lessons learned to the anticipation of the challenges of round two. Topics to be discussed include:

• Understanding how drug prices will be negotiated under the IRA
  • Identifying what the current Administration and HHS are looking at in terms of negotiations?
  • What has the first round of negotiations revealed in terms of both the government’s and manufacturers’ expectations?
• Dissecting the IRA implementation process
  • How does it differ from negotiations in the pre-IRA era?
• Identifying key components that manufacturers need to keep in mind for successful negotiations
• Anticipating the next list of drugs that will be subject to the IRA and what their timelines will look like